U.S. Food and Drug Administration officially approved the weekly injection of semaglutide under the brand name of Ozempic. This therapy along with healthy diet and exercise would improve glycemic control in adults with type 2 diabetes. The side effects of semaglutide was found to be mild or moderate nausea.
It was great news in the field of medicine when geneticists from University of California, Los Angeles (UCLA) created a novel technique to hunt for natural hormones that would enhance cell communication to play a major role in treating obesity, diabetes and cardiovascular diseases. Scientists discovered two hormones called "notum" and "lipocalin-5", which would aid in the fat burning process. Lipocalin-5 also enhances metabolism and absorption of dietary nutrients by reducing the risk of diabetes and obesity.
An ultimate focus on a specific protein named myostatin has led to the discovery of a muscle building pill, that could easily reduce gym visits. Suppression of myostatin production could increase healthier muscle mass, which would act as markers in improving kidney and heart health.
New research has identified a mechanism in the body that appears to act as a kind of internal bathroom scale, registering body weight and telling the brain to reduce or increase food intake as necessary.
Obesity is often attributed to a simple equation: People are eating too much and exercising too little. But evidence is growing that at least some of the weight gain that plagues modern humans is predetermined.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.